Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Payables (2020 - 2025)

Historic Payables for Evotec SE (EVO) over the last 8 years, with Q3 2025 value amounting to $57850.7.

  • Evotec SE's Payables fell 2463.33% to $57850.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $57850.7, marking a year-over-year decrease of 2463.33%. This contributed to the annual value of $91676.9 for FY2024, which is 9993.66% down from last year.
  • Evotec SE's Payables amounted to $57850.7 in Q3 2025, which was down 2463.33% from $65635.5 recorded in Q2 2025.
  • In the past 5 years, Evotec SE's Payables registered a high of $144.5 million during Q4 2023, and its lowest value of -$86317.4 during Q2 2022.
  • Its 5-year average for Payables is $27.3 million, with a median of $80320.7 in 2022.
  • In the last 5 years, Evotec SE's Payables skyrocketed by 6370.75% in 2021 and then tumbled by 9993.66% in 2024.
  • Quarter analysis of 5 years shows Evotec SE's Payables stood at $83.1 million in 2021, then grew by 19.5% to $99.2 million in 2022, then surged by 45.62% to $144.5 million in 2023, then plummeted by 99.94% to $91676.9 in 2024, then crashed by 36.9% to $57850.7 in 2025.
  • Its Payables was $57850.7 in Q3 2025, compared to $65635.5 in Q2 2025 and $64479.5 in Q1 2025.